Abstract
Objectives
The objectives were to determine the frequency with which pulse oximetry identifies critical congenital heart defects in asymptomatic full-term and late preterm newborns using the AAP expert panel algorithm in a variety of different hospital settings and to evaluate the impact of altitude on the rate of positive screens.
Methods
We conducted a prospective clinical study of implementation of a newborn pulse oximetry screening for congenital heart disease in 34 independent hospitals. Infants were eligible for enrollment if their gestational age was 35–44 weeks.
Results
Of the 34 sites which enrolled infants into our study, 24 were located at or below 2000 feet; 5 were located between 4700 and 6000 feet and 5 were located above 6000 feet in altitude. We screened 6109 infants; 65 (1.1%) had a positive screen. There were no differences in median gestational age, birth weight, mode of delivery or race/ethnicity for infants with a positive screen compared to infants with a negative screen. Infants with positive screens were more often male and more often born at sites located at high altitudes. The frequency of a positive screen increased from 0.2% for infants born at sites at or less than 2000 feet to 6% for sites located above 6000 feet. We stopped enrollment at the site located at 8163 feet after enrolling 65 infants because 23 (35%) were positive.
Conclusions
Screening infants for critical cardiac defects at altitude is complicated by the increased false positive screens.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hom LA, Martin GR. Newborn critical congenital heart disease screening using pulse oximetry: nursing aspects. Am J Perinatol. 2016;33:1072–5.
Oster ME, Kochilas L. Screening for critical congenital heart disease. Clin Perinatol. 2016;43:73–80.
Oster ME, Aucott SW, Glidewell J, Hackell J, Kochilas L, Martin GR. et al. Lessons learned from newborn screening for critical congenital heart defects. Pediatrics. 2016;137:pii: e20154573
Pflugeisen BM, Amoroso PJ, Zook D, Welke KF, Reedy A, Park MV. Quality improvement measures in pulse-oximetry newborn heart screening: a time series analysis. Pediatrics. 2015;135:e531–e539.
Gong A, Guillory C, Creel L, Livingtson JE, McKee-Garrett TM, Fortunov R. A multicenter initiative for critical congenital heart disease newborn screening in Texas neonatal intensive care units. Am J Perinatol. 2017;34:839–44.
Wright J, Kohn M, Niermeyer S, Rausch CM. Feasibility of critical congenital heart disease newborn screening at moderate altitude. Pediatrics. 2014;133:e561–e569.
Han LM, Klewer SE, Blank KM, Seckeler MD, Barber BJ. Feasibility of pulse oximetry screening for critical congenital heart disease at 2643-foot elevation. Pediatr Cardiol. 2013;34:1803–7.
Samuel TY, Bromiker R, Mimouni FB, Picard E, Lahav S, Mandel D. et al. Newborn oxygen saturation at mild altitude versus sea level: implications for neonatal screening for critical congenital heart disease. Acta Paediatr. 2013;102:379–84.
Paranka M, Brown M, Thomas P, Peabody J, Clark R. Are very low birth weight infants born at high altitude at greater risk for adverse outcomes?. J Pediatr. 2001;139:669–72.
Section on Transport Medicine AAP, Alexander SN, Romito J. Guidelines for Air & Ground Transport of Neonatal and Pediatric Patients Manual, 4th Ed. American Academy of Pediatrics; 2015. 345 Park Boulevard, Itasca, IL, 60143USA.
Ailes EC, Gilboa SM, Honein MA, Oster ME. Estimated number of infants detected and missed by critical congenital heart defect screening. Pediatrics. 2015;135:1000–8.
Klausner R, Shapiro ED, Elder RW, Colson E, Loyal J. Evaluation of a screening program to detect critical congenital heart defects in newborns. Hosp Pediatr. 2017;7:214–8.
John C, Phillips J, Hamilton C, Lastliger A. Implementing Universal pulse oximetry screening in West Virginia: findings from year one. W V Med J. 2016;112:42–46.
Acknowledgements
Principal investigators were as follows: Kaashif Aqeeb Ahmad, Methodist Children’s Hospital (San Antonio, TX); Jennifer Anderson, Presbyterian Hospital (Albuquerque, NM); Travis W. Anschutz, Eastern Idaho Regional Medical Center (Idaho Falls, ID); Martin Anyebuno, Swedish American Hospital (Rockford, IL); James Berger, Ogden Regional Medical Center (Ogden, UT); G. Michael Bixler, Miami Valley Hospital (Dayton, OH); Jeffrey M. Brown, Vail Valley Medical Center (Vail, CO); Edward Co, Integris Baptist Medical Center (Oklahoma City, OK); Delphine M. Eichorst, Rocky Mountain Hospital for Children at Presbyterian/St. Luke’s Medical Center (Denver, CO); Jenelle Ferry, Mease Countryside Hospital (Safety Harbor, FL) and Morton Plant Hospital (Clearwater, FL); Oluwamayowale Folaranmi, PinnacleHealth Harrisburg Hospital (Harrisburg, PA); Adrian Garcia, Memorial Hermann The Woodlands Hospital (The Woodlands, TX); Claudia Hart, Flagstaff Medical Center (Flagstaff, AZ); Michael T. Hinkes, Northside Hospital (Atlanta, GA); Mary R. Laird, UCHealth at Memorial Hospital Central and Memorial Hospital North (Colorado Springs, CO); Kartik Mody, St. Joseph’s Hospital & Medical Center (Phoenix, AZ); Stephen T. Moffitt, Capital Health Regional Medical Center (Trenton, NJ); Kay Mohsini, Covenant Medical Center (Saginaw, MI); Maria Imelda Bautista-Navarro, Stormont Vail Regional Health Center (Topeka, KS); Michael S. Paranka, The Medical Center of Aurora (Aurora, CO) and Sky Ridge Medical Center (Lone Tree, CO); Jay A. Patel, Banner Good Samaritan Medical Center (Phoenix, AZ); George C. Powers, The Children’s Hospital of San Antonio (San Antonio, TX); Isabel Basaldu-Prado, St. Luke’s Baptist Hospital (San Antonio, TX); Andres Rodriguez, Broward Health Coral Springs (Coral Springs, FL); Elaine M. Sillos, Presbyterian Hospital (Albuquerque, NM); Susan F. Townsend, Memorial Hospital North (Colorado Springs, CO); Lakshmy Vaidyanathan, Seton Medical Center (Austin, TX); Mary Wearden, North Central Baptist Hospital (San Antonio, TX); David Weisoly, Baylor Scott & White Medical Center-Carrollton (Carrollton, TX); Robert D. White, Elkhart General Hospital (Elkhart, IN). Contributors were as follows: Carol Beck, The Medical Center of Aurora (Aurora, CO); Janna Benston, Northside Hospital (Atlanta, GA); Lesli Blanchard, Eastern Idaho Regional Medical Center (Idaho Falls, ID); Abigail Bye, Swedish American Hospital (Rockford, IL); Julie Clowers, Baylor Scott & White Medical Center-Carrollton (Carrollton, TX); Nancy Fraire, UCHealth at Memorial Hospital Central (Colorado Springs, CO); Juliet Garbow, Covenant HealthCare (Saginaw, MI); Katrina Grier, Northside Hospital (Atlanta, GA); Jacqueline Hoffman, Mease Countryside Hospital (Safety Harbor, FL) and Morton Plant Hospital (Clearwater, FL); Monica Jaynes, Baylor Scott & White Medical Center-Carrollton (Carrollton, TX); Charmaine Kathen, Methodist Children’s Hospital (San Antonio, TX); Sue Mackey, Miami Valley Hospital (Dayton, OH); Stephanie Mahan, The Children’s Hospital of San Antonio (San Antonio, TX); Debra McCann, Integris Baptist Medical Center (Oklahoma City, OK); Becky Micetic, Banner - University Medical Center Phoenix (Phoenix, AZ); Cathryn Moody, Memorial Hermann The Woodlands Hospital (The Woodlands, TX); Jamie K. Phelan, Sky Ridge Medical Center (Lone Tree, CO); Barbara Ritter, PinnacleHealth Harrisburg Hospital (Harrisburg, PA); Kathy Roper, Vail Valley Medical Center (Vail, CO); Janet Rosebrough, Stormont Vail Regional Health Center (Topeka, KS); Steve Smith, Ogden Regional Medical Center (Ogden, UT); Crystal Tolbert, Sacred Heart Hospital – Pensacola (Pensacola, FL); Delores Troyer, Elkhart General Hospital (Elkhart, IN); Christine Wade, Banner - University Medical Center Phoenix (Phoenix, AZ). We also acknowledge Alex R. Kemper for helping with study design and for reviewing the manuscript and offering important edits. Administrative support was as follows: Carole Benson, Jaclyn Cohen, Nalina Fisher, Theresa Katich, Kathy McCarty, Octavia Reed, Vernice Vixamar and Shannon Weeks.
Author contributions
MSP, JMB, MVP and RHC contributed to the conception and design of the study and provided extensive editorial input into the final paper. RHC wrote the first draft, and managed edits provided by the co-authors of the manuscript. ASK managed the monitoring and conduct of the study protocol and contributed to the drafting and revision of the article for important intellectual content. RDW contributed to the conception and design and interpretation of data, and critical revisions for important intellectual content. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Funding
This work was supported by Pediatrix Medical Group. No outside honorarium, grant, or other form of payment was given to anyone to produce the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Paranka, M.S., Brown, J.M., White, R.D. et al. The impact of altitude on screening for critical congenital heart disease. J Perinatol 38, 530–536 (2018). https://doi.org/10.1038/s41372-018-0043-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41372-018-0043-9
This article is cited by
-
A new algorithm DEtectS critical Congenital Heart Disease at different altitudes: ANDES-CHD study
Journal of Perinatology (2024)
-
Trajectories of oxygen saturation within 6–72 hours after birth in neonates at moderate altitude: a prospective longitudinal cohort study
World Journal of Pediatrics (2023)
-
Lower pass threshold (≥93%) for critical congenital heart disease screening at high altitude prevents repeat screening and reduces false positives
Journal of Perinatology (2022)